Janus Henderson Group PLC Eliem Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $194 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$4.11 - $5.42 $1.74 Million - $2.29 Million
-422,295 Reduced 11.71%
3,184,200 $13.1 Million
Q3 2024

Nov 14, 2024
BUY
$4.98 - $8.93 $1.76 Million - $3.15 Million
352,507 Added 10.83%
3,606,495 $18.4 Million
Q2 2024

Aug 14, 2024
BUY
$2.6 - $10.2 $8.46 Million - $33.2 Million
3,253,988 New
3,253,988 $23.1 Million

Others Institutions Holding ELYM

# of Institutions
68
Shares Held
49.5M
Call Options Held
0
Put Options Held
0
View Full List

About Eliem Therapeutics, Inc.

ELYM Quotes by TradingView
  • Ticker ELYM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,567,700
  • Market Cap $109M
  • Description
  • Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...
More about ELYM
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email